Renalytix is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosis™ for kidney health. KidneyIntelX is a laboratory developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D and early CKD (stages 1-3). By understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs. www.kidneyintelX.com. www.renalytix.com
Additional Info
First-time Exhibitor:
No